Global Viral Inactivation Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18739399

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18739399

Global Viral Inactivation Databank Market Report

The Viral Inactivation market was valued at $2,538.3 Million in 2022, and is projected to reach $6,095.3 Million by 2031 growing at a CAGR of 10.28% from 2023 to 2031. Kits and reagents segment is expected to be the highest contributor to this market, with $1,501.9 Million in 2022, and is anticipated to reach $3,741.9 Million by 2031, registering a CAGR of 10.74%. Kits and reagents and Systems segments collectively expected to account for about 85.6% share of the Viral Inactivation market in 2022, with the former constituting around 59.2% share. Kits and reagents and Services segments are expected to witness significant growth rates at a CAGR of 10.74% and 10.05% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 73.5% in the overall Viral Inactivation market in 2022, and is anticipated to reach 75.5% by 2031.

1. Global Viral Inactivation Market, By Product: 1.1. Overview; 1.2. Kits and reagents; 1.2.1 Kits and reagents Market, By Region; 1.2.1.1 North America Kits and reagents Market, By Country; 1.2.1.2 Europe Kits and reagents Market, By Country; 1.2.1.3 Asia-Pacific Kits and reagents Market, By Country; 1.2.1.4 Rest of World Kits and reagents Market, By Country; 1.3. Systems; 1.3.1 Systems Market, By Region; 1.3.1.1 North America Systems Market, By Country; 1.3.1.2 Europe Systems Market, By Country; 1.3.1.3 Asia-Pacific Systems Market, By Country; 1.3.1.4 Rest of World Systems Market, By Country; 1.4. Services; 1.4.1 Services Market, By Region; 1.4.1.1 North America Services Market, By Country; 1.4.1.2 Europe Services Market, By Country; 1.4.1.3 Asia-Pacific Services Market, By Country; 1.4.1.4 Rest of World Services Market, By Country
2. Global Viral Inactivation Market, By Application: 2.1. Overview; 2.2. Vaccines and Therapeutics; 2.2.1 Vaccines and Therapeutics Market, By Region; 2.2.1.1 North America Vaccines and Therapeutics Market, By Country; 2.2.1.2 Europe Vaccines and Therapeutics Market, By Country; 2.2.1.3 Asia-Pacific Vaccines and Therapeutics Market, By Country; 2.2.1.4 Rest of World Vaccines and Therapeutics Market, By Country; 2.3. Stem Cell Products; 2.3.1 Stem Cell Products Market, By Region; 2.3.1.1 North America Stem Cell Products Market, By Country; 2.3.1.2 Europe Stem Cell Products Market, By Country; 2.3.1.3 Asia-Pacific Stem Cell Products Market, By Country; 2.3.1.4 Rest of World Stem Cell Products Market, By Country; 2.4. Blood and Blood Products; 2.4.1 Blood and Blood Products Market, By Region; 2.4.1.1 North America Blood and Blood Products Market, By Country; 2.4.1.2 Europe Blood and Blood Products Market, By Country; 2.4.1.3 Asia-Pacific Blood and Blood Products Market, By Country; 2.4.1.4 Rest of World Blood and Blood Products Market, By Country; 2.5. Tissue/ Tissue Products; 2.5.1 Tissue/ Tissue Products Market, By Region; 2.5.1.1 North America Tissue/ Tissue Products Market, By Country; 2.5.1.2 Europe Tissue/ Tissue Products Market, By Country; 2.5.1.3 Asia-Pacific Tissue/ Tissue Products Market, By Country; 2.5.1.4 Rest of World Tissue/ Tissue Products Market, By Country; 2.6. Cellular and Gene Therapy; 2.6.1 Cellular and Gene Therapy Market, By Region; 2.6.1.1 North America Cellular and Gene Therapy Market, By Country; 2.6.1.2 Europe Cellular and Gene Therapy Market, By Country; 2.6.1.3 Asia-Pacific Cellular and Gene Therapy Market, By Country; 2.6.1.4 Rest of World Cellular and Gene Therapy Market, By Country
3. Global Viral Inactivation Market, By End-Use: 3.1. Overview; 3.2. Pharmaceutical and Biotechnology Companies; 3.2.1 Pharmaceutical and Biotechnology Companies Market, By Region; 3.2.1.1 North America Pharmaceutical and Biotechnology Companies Market, By Country; 3.2.1.2 Europe Pharmaceutical and Biotechnology Companies Market, By Country; 3.2.1.3 Asia-Pacific Pharmaceutical and Biotechnology Companies Market, By Country; 3.2.1.4 Rest of World Pharmaceutical and Biotechnology Companies Market, By Country; 3.3. CROs; 3.3.1 CROs Market, By Region; 3.3.1.1 North America CROs Market, By Country; 3.3.1.2 Europe CROs Market, By Country; 3.3.1.3 Asia-Pacific CROs Market, By Country; 3.3.1.4 Rest of World CROs Market, By Country; 3.4. Academic and Research Institutes; 3.4.1 Academic and Research Institutes Market, By Region; 3.4.1.1 North America Academic and Research Institutes Market, By Country; 3.4.1.2 Europe Academic and Research Institutes Market, By Country; 3.4.1.3 Asia-Pacific Academic and Research Institutes Market, By Country; 3.4.1.4 Rest of World Academic and Research Institutes Market, By Country; 3.5. Other End-Uses; 3.5.1 Other End-Uses Market, By Region; 3.5.1.1 North America Other End-Uses Market, By Country; 3.5.1.2 Europe Other End-Uses Market, By Country; 3.5.1.3 Asia-Pacific Other End-Uses Market, By Country; 3.5.1.4 Rest of World Other End-Uses Market, By Country
4. Global Viral Inactivation Market, By Region: 4.1. Overview; 4.2. North America; 4.2.1 North America Viral Inactivation Market, By Product; 4.2.2 North America Viral Inactivation Market, By Application; 4.2.3 North America Viral Inactivation Market, By End-Use; 4.2.4 North America Viral Inactivation Market, By Country; 4.2.4.1 U.S.; 4.2.4.1.1 U.S. Viral Inactivation Market, By Product; 4.2.4.1.2 U.S. Viral Inactivation Market, By Application; 4.2.4.1.3 U.S. Viral Inactivation Market, By End-Use; 4.2.4.2 Canada; 4.2.4.2.1 Canada Viral Inactivation Market, By Product; 4.2.4.2.2 Canada Viral Inactivation Market, By Application; 4.2.4.2.3 Canada Viral Inactivation Market, By End-Use; 4.3. Europe; 4.3.1 Europe Viral Inactivation Market, By Product; 4.3.2 Europe Viral Inactivation Market, By Application; 4.3.3 Europe Viral Inactivation Market, By End-Use; 4.3.4 Europe Viral Inactivation Market, By Country; 4.3.4.1 Germany; 4.3.4.1.1 Germany Viral Inactivation Market, By Product; 4.3.4.1.2 Germany Viral Inactivation Market, By Application; 4.3.4.1.3 Germany Viral Inactivation Market, By End-Use; 4.3.4.2 U.K.; 4.3.4.2.1 U.K. Viral Inactivation Market, By Product; 4.3.4.2.2 U.K. Viral Inactivation Market, By Application; 4.3.4.2.3 U.K. Viral Inactivation Market, By End-Use; 4.3.4.3 France; 4.3.4.3.1 France Viral Inactivation Market, By Product; 4.3.4.3.2 France Viral Inactivation Market, By Application; 4.3.4.3.3 France Viral Inactivation Market, By End-Use; 4.3.4.4 Italy; 4.3.4.4.1 Italy Viral Inactivation Market, By Product; 4.3.4.4.2 Italy Viral Inactivation Market, By Application; 4.3.4.4.3 Italy Viral Inactivation Market, By End-Use; 4.3.4.5 Spain; 4.3.4.5.1 Spain Viral Inactivation Market, By Product; 4.3.4.5.2 Spain Viral Inactivation Market, By Application; 4.3.4.5.3 Spain Viral Inactivation Market, By End-Use; 4.3.4.6 Rest of Europe; 4.3.4.6.1 Rest of Europe Viral Inactivation Market, By Product; 4.3.4.6.2 Rest of Europe Viral Inactivation Market, By Application; 4.3.4.6.3 Rest of Europe Viral Inactivation Market, By End-Use; 4.4. Asia-Pacific; 4.4.1 Asia-Pacific Viral Inactivation Market, By Product; 4.4.2 Asia-Pacific Viral Inactivation Market, By Application; 4.4.3 Asia-Pacific Viral Inactivation Market, By End-Use; 4.4.4 Asia-Pacific Viral Inactivation Market, By Country; 4.4.4.1 China; 4.4.4.1.1 China Viral Inactivation Market, By Product; 4.4.4.1.2 China Viral Inactivation Market, By Application; 4.4.4.1.3 China Viral Inactivation Market, By End-Use; 4.4.4.2 Japan; 4.4.4.2.1 Japan Viral Inactivation Market, By Product; 4.4.4.2.2 Japan Viral Inactivation Market, By Application; 4.4.4.2.3 Japan Viral Inactivation Market, By End-Use; 4.4.4.3 South Korea; 4.4.4.3.1 South Korea Viral Inactivation Market, By Product; 4.4.4.3.2 South Korea Viral Inactivation Market, By Application; 4.4.4.3.3 South Korea Viral Inactivation Market, By End-Use; 4.4.4.4 India; 4.4.4.4.1 India Viral Inactivation Market, By Product; 4.4.4.4.2 India Viral Inactivation Market, By Application; 4.4.4.4.3 India Viral Inactivation Market, By End-Use; 4.4.4.5 Indonesia; 4.4.4.5.1 Indonesia Viral Inactivation Market, By Product; 4.4.4.5.2 Indonesia Viral Inactivation Market, By Application; 4.4.4.5.3 Indonesia Viral Inactivation Market, By End-Use; 4.4.4.6 Rest of Asia; 4.4.4.6.1 Rest of Asia Viral Inactivation Market, By Product; 4.4.4.6.2 Rest of Asia Viral Inactivation Market, By Application; 4.4.4.6.3 Rest of Asia Viral Inactivation Market, By End-Use; 4.5. Rest of World; 4.5.1 Rest of World Viral Inactivation Market, By Product; 4.5.2 Rest of World Viral Inactivation Market, By Application; 4.5.3 Rest of World Viral Inactivation Market, By End-Use; 4.5.4 Rest of World Viral Inactivation Market, By Country; 4.5.4.1 Brazil; 4.5.4.1.1 Brazil Viral Inactivation Market, By Product; 4.5.4.1.2 Brazil Viral Inactivation Market, By Application; 4.5.4.1.3 Brazil Viral Inactivation Market, By End-Use; 4.5.4.2 Mexico; 4.5.4.2.1 Mexico Viral Inactivation Market, By Product; 4.5.4.2.2 Mexico Viral Inactivation Market, By Application; 4.5.4.2.3 Mexico Viral Inactivation Market, By End-Use; 4.5.4.3 South Africa; 4.5.4.3.1 South Africa Viral Inactivation Market, By Product; 4.5.4.3.2 South Africa Viral Inactivation Market, By Application; 4.5.4.3.3 South Africa Viral Inactivation Market, By End-Use; 4.5.4.4 Australia; 4.5.4.4.1 Australia Viral Inactivation Market, By Product; 4.5.4.4.2 Australia Viral Inactivation Market, By Application; 4.5.4.4.3 Australia Viral Inactivation Market, By End-Use; 4.5.4.5 ROW Countries; 4.5.4.5.1 ROW Countries Viral Inactivation Market, By Product; 4.5.4.5.2 ROW Countries Viral Inactivation Market, By Application; 4.5.4.5.3 ROW Countries Viral Inactivation Market, By End-Use; ROW Countries Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD LIST OF TABLES; TABLE 1. Global Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 2. Kits and reagents Market Value, By Region, 2022-2031, Million USD; TABLE 3. North America Kits and reagents Market Value, By Country, 2022-2031, Million USD; TABLE 4. Europe Kits and reagents Market Value, By Country, 2022-2031, Million USD; TABLE 5. Asia-Pacific Kits and reagents Market Value, By Country, 2022-2031, Million USD; TABLE 6. Rest of World Kits and reagents Market Value, By Country, 2022-2031, Million USD; TABLE 7. Systems Market Value, By Region, 2022-2031, Million USD; TABLE 8. North America Systems Market Value, By Country, 2022-2031, Million USD; TABLE 9. Europe Systems Market Value, By Country, 2022-2031, Million USD; TABLE 10. Asia-Pacific Systems Market Value, By Country, 2022-2031, Million USD; TABLE 11. Rest of World Systems Market Value, By Country, 2022-2031, Million USD; TABLE 12. Services Market Value, By Region, 2022-2031, Million USD; TABLE 13. North America Services Market Value, By Country, 2022-2031, Million USD; TABLE 14. Europe Services Market Value, By Country, 2022-2031, Million USD; TABLE 15. Asia-Pacific Services Market Value, By Country, 2022-2031, Million USD; TABLE 16. Rest of World Services Market Value, By Country, 2022-2031, Million USD; TABLE 17. Global Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 18. Vaccines and Therapeutics Market Value, By Region, 2022-2031, Million USD; TABLE 19. North America Vaccines and Therapeutics Market Value, By Country, 2022-2031, Million USD; TABLE 20. Europe Vaccines and Therapeutics Market Value, By Country, 2022-2031, Million USD; TABLE 21. Asia-Pacific Vaccines and Therapeutics Market Value, By Country, 2022-2031, Million USD; TABLE 22. Rest of World Vaccines and Therapeutics Market Value, By Country, 2022-2031, Million USD; TABLE 23. Stem Cell Products Market Value, By Region, 2022-2031, Million USD; TABLE 24. North America Stem Cell Products Market Value, By Country, 2022-2031, Million USD; TABLE 25. Europe Stem Cell Products Market Value, By Country, 2022-2031, Million USD; TABLE 26. Asia-Pacific Stem Cell Products Market Value, By Country, 2022-2031, Million USD; TABLE 27. Rest of World Stem Cell Products Market Value, By Country, 2022-2031, Million USD; TABLE 28. Blood and Blood Products Market Value, By Region, 2022-2031, Million USD; TABLE 29. North America Blood and Blood Products Market Value, By Country, 2022-2031, Million USD; TABLE 30. Europe Blood and Blood Products Market Value, By Country, 2022-2031, Million USD; TABLE 31. Asia-Pacific Blood and Blood Products Market Value, By Country, 2022-2031, Million USD; TABLE 32. Rest of World Blood and Blood Products Market Value, By Country, 2022-2031, Million USD; TABLE 33. Tissue/ Tissue Products Market Value, By Region, 2022-2031, Million USD; TABLE 34. North America Tissue/ Tissue Products Market Value, By Country, 2022-2031, Million USD; TABLE 35. Europe Tissue/ Tissue Products Market Value, By Country, 2022-2031, Million USD; TABLE 36. Asia-Pacific Tissue/ Tissue Products Market Value, By Country, 2022-2031, Million USD; TABLE 37. Rest of World Tissue/ Tissue Products Market Value, By Country, 2022-2031, Million USD; TABLE 38. Cellular and Gene Therapy Market Value, By Region, 2022-2031, Million USD; TABLE 39. North America Cellular and Gene Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 40. Europe Cellular and Gene Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 41. Asia-Pacific Cellular and Gene Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 42. Rest of World Cellular and Gene Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 43. Global Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 44. Pharmaceutical and Biotechnology Companies Market Value, By Region, 2022-2031, Million USD; TABLE 45. North America Pharmaceutical and Biotechnology Companies Market Value, By Country, 2022-2031, Million USD; TABLE 46. Europe Pharmaceutical and Biotechnology Companies Market Value, By Country, 2022-2031, Million USD; TABLE 47. Asia-Pacific Pharmaceutical and Biotechnology Companies Market Value, By Country, 2022-2031, Million USD; TABLE 48. Rest of World Pharmaceutical and Biotechnology Companies Market Value, By Country, 2022-2031, Million USD; TABLE 49. CROs Market Value, By Region, 2022-2031, Million USD; TABLE 50. North America CROs Market Value, By Country, 2022-2031, Million USD; TABLE 51. Europe CROs Market Value, By Country, 2022-2031, Million USD; TABLE 52. Asia-Pacific CROs Market Value, By Country, 2022-2031, Million USD; TABLE 53. Rest of World CROs Market Value, By Country, 2022-2031, Million USD; TABLE 54. Academic and Research Institutes Market Value, By Region, 2022-2031, Million USD; TABLE 55. North America Academic and Research Institutes Market Value, By Country, 2022-2031, Million USD; TABLE 56. Europe Academic and Research Institutes Market Value, By Country, 2022-2031, Million USD; TABLE 57. Asia-Pacific Academic and Research Institutes Market Value, By Country, 2022-2031, Million USD; TABLE 58. Rest of World Academic and Research Institutes Market Value, By Country, 2022-2031, Million USD; TABLE 59. Other End-Uses Market Value, By Region, 2022-2031, Million USD; TABLE 60. North America Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 61. Europe Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 62. Asia-Pacific Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 63. Rest of World Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 64. Global Viral Inactivation Market Value, By Region, 2022-2031, Million USD; TABLE 65. North America Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 66. North America Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 67. North America Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 68. North America Viral Inactivation Market Value, By Country, 2022-2031, Million USD; TABLE 69. U.S. Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 70. U.S. Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 71. U.S. Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 72. Canada Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 73. Canada Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 74. Canada Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 75. Europe Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 76. Europe Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 77. Europe Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 78. Europe Viral Inactivation Market Value, By Country, 2022-2031, Million USD; TABLE 79. Germany Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 80. Germany Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 81. Germany Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 82. U.K. Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 83. U.K. Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 84. U.K. Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 85. France Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 86. France Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 87. France Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 88. Italy Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 89. Italy Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 90. Italy Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 91. Spain Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 92. Spain Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 93. Spain Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 94. Rest of Europe Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 95. Rest of Europe Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 96. Rest of Europe Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 97. Asia-Pacific Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 98. Asia-Pacific Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 99. Asia-Pacific Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 100. Asia-Pacific Viral Inactivation Market Value, By Country, 2022-2031, Million USD; TABLE 101. China Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 102. China Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 103. China Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 104. Japan Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 105. Japan Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 106. Japan Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 107. South Korea Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 108. South Korea Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 109. South Korea Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 110. India Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 111. India Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 112. India Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 113. Indonesia Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 114. Indonesia Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 115. Indonesia Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 116. Rest of Asia Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 117. Rest of Asia Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 118. Rest of Asia Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 119. Rest of World Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 120. Rest of World Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 121. Rest of World Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 122. Rest of World Viral Inactivation Market Value, By Country, 2022-2031, Million USD; TABLE 123. Brazil Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 124. Brazil Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 125. Brazil Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 126. Mexico Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 127. Mexico Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 128. Mexico Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 129. South Africa Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 130. South Africa Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 131. South Africa Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 132. Australia Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 133. Australia Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 134. Australia Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; TABLE 135. ROW Countries Viral Inactivation Market Value, By Product, 2022-2031, Million USD; TABLE 136. ROW Countries Viral Inactivation Market Value, By Application, 2022-2031, Million USD; TABLE 137. ROW Countries Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD; ROW Countries Viral Inactivation Market Value, By End-Use, 2022-2031, Million USD